{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:59:01Z","timestamp":1786993141634,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Amneal Pharmaceuticals"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jpba.2020.113292","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T12:18:47Z","timestamp":1592914727000},"page":"113292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Quantitative X-ray fluorescence analysis: Trace level detection of toxic elemental impurities in drug product by ED-XRF spectrometer"],"prefix":"10.1016","volume":"189","author":[{"given":"Anirban Roy","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelesh","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigar","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mukharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113292_bib0005","unstructured":"https:\/\/www.fda.gov\/drugs\/pharmaceutical-quality-resources\/elemental-impurities."},{"key":"10.1016\/j.jpba.2020.113292_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.talanta.2017.04.034","article-title":"Simultaneous determination and speciation analysis of arsenic and chromium in iron supplements used for iron-deficiency anemia treatment by HPLC-ICP-MS","volume":"170","author":"Araujo-Barbosa","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2020.113292_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trac.2017.09.011","article-title":"Impact and practicability of recently introduced requirements on elemental impurities","volume":"101","author":"Pohl","year":"2018","journal-title":"Trac Trends Anal. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2020.113292_bib0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/0003702816670912","article-title":"Determination of nickel and manganese contaminants in pharmaceutical Iron supplements using energy dispersive X-ray fluorescence","volume":"71","author":"Cardoso","year":"2017","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.jpba.2020.113292_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jpba.2017.06.045","article-title":"Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP <232>\/<233>","volume":"145","author":"Chahrour","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.jpba.2020.113292_bib0030","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1039\/b904064a","article-title":"Determination of metal residues in active pharmaceutical ingredients according to European current legislation by using X-ray fluorescence spectrometry","volume":"24","author":"Margu\u00ed","year":"2009","journal-title":"J. Anal. At. Spectrom."},{"key":"10.1016\/j.jpba.2020.113292_bib0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0003-2670(01)80736-4","article-title":"Photometric determination of osmium with thiourea after extraction of the tetroxide","volume":"9","author":"Sauerbrunn","year":"1953","journal-title":"Anal. Chim. Acta"},{"issue":"14","key":"10.1016\/j.jpba.2020.113292_bib0040","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1021\/ja01110a071","article-title":"The reaction of osmium tetroxide with thiourea","volume":"75","author":"Sauerbrunn","year":"1953","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.jpba.2020.113292_bib0045","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0731-7085(00)00361-7","article-title":"A multi-element ICP-MS survey method as an alternative to the heavy metals limit test for pharmaceutical materials","volume":"23","author":"Wang","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2020.113292_bib0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1039\/b403510k","article-title":"Collision and reaction cells in atomic mass spectrometry: development, status, and applications","volume":"19","author":"Koppenaal","year":"2004","journal-title":"J. Anal. At. Spectrom."},{"key":"10.1016\/j.jpba.2020.113292_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpba.2014.02.016","article-title":"Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>\/<233>","volume":"95","author":"Fischer","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2020.113292_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/0929866523666161213094936","article-title":"Inductively coupled plasma mass spectrometry (ICP-MS) applications in quantitative proteomics","volume":"24","author":"Chahrour","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.jpba.2020.113292_bib0065","unstructured":"https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/chemical-medicines\/key-issues\/c232-usp-39.pdf."},{"key":"10.1016\/j.jpba.2020.113292_bib0070","unstructured":"https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/our-work\/chemical-medicines\/key-issues\/233_ElementalImpuritiesProcedures.pdf."},{"issue":"2","key":"10.1016\/j.jpba.2020.113292_bib0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/xrs.725","article-title":"Wavelength-dispersive x-ray fluorescence measurements on organic matrices: application to milk-based products","volume":"33","author":"Perring","year":"2004","journal-title":"X-ray Spectrom."},{"key":"10.1016\/j.jpba.2020.113292_bib0080","article-title":"Application of X-ray fluorescence spectrometry for screening pharmaceutical products for elemental Impurities according to ICH guideline Q3D","volume":"179","author":"Sauer","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113292_bib0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sab.2013.05.024","article-title":"Determination of platinum group metal catalyst residues in active pharmaceutical ingredients by means of total reflection X-ray spectrometry","volume":"86","author":"Margu\u00ed","year":"2013","journal-title":"Spectrochim. Acta Part B At. Spectrosc."},{"key":"10.1016\/j.jpba.2020.113292_bib0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2012.01.037","article-title":"Applicability of total reflection X-ray fluorescence (TXRF) as a screening platform for pharmaceutical inorganic impurity analysis","volume":"63","author":"Shaw","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113292_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpba.2011.12.020","article-title":"The use of total reflectance X-ray fluorescence (TXRF) for the determination of metals in the pharmaceutical industry","volume":"62","author":"Antosz","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2020.113292_bib0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/ac1028598","article-title":"Rapid limit tests for metal impurities in pharmaceutical materials by X-ray fluorescence spectroscopy using wavelet transform filtering","volume":"83","author":"Arzhantsev","year":"2011","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.jpba.2020.113292_bib0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/xrs.2788","article-title":"The comparative verification of calibration curve and background fundamental parameter methods for impurity analysis in drug materials","volume":"46","author":"Furukawa","year":"2017","journal-title":"X-ray Spectrom."},{"issue":"3","key":"10.1016\/j.jpba.2020.113292_bib0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/xrs.1300180308","article-title":"Software for energy-dispersive X-ray fluorescence","volume":"18","author":"Rindby","year":"1989","journal-title":"X-ray Spectrom."},{"issue":"4","key":"10.1016\/j.jpba.2020.113292_bib0115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/etc.5620160427","article-title":"Study of heavy metals and other elements in macrophyte algae using energy-dispersive x-ray fluorescence","volume":"16","author":"Carvalho","year":"1997","journal-title":"Environ. Toxicol. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519330493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519330493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:05:39Z","timestamp":1760000739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519330493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"alternative-id":["S0731708519330493"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113292","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative X-ray fluorescence analysis: Trace level detection of toxic elemental impurities in drug product by ED-XRF spectrometer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113292"}}